ClinicalTrials.gg
Not yet recruitingNCT07816016fREMSUpdated Sep 15, 2026

fREMS for Mortality Prediction in TBI

An observational study in TBI and TBI Traumatic Brain Injury, sponsored by Al-Nahrain University. Not yet recruiting at 1 site in Iraq. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Al-Nahrain University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
16 Years and older
Sex
All
01

Study summary

This prospective observational study aims to develop and internally validate a new clinical score, the FOUR-Rapid Emergency Medicine Score (fREMS), for predicting in-hospital mortality in patients with traumatic brain injury (TBI). The study will assess whether combining the Full Outline of UnResponsiveness (FOUR) score with physiological and clinical parameters from the Rapid Emergency Medicine Score (REMS) can improve early mortality prediction. The main question it aims to answer is:

Can the fREMS score accurately predict the risk of in-hospital mortality in patients with traumatic brain injury?

Data on demographic characteristics, vital signs, neurological assessment, and other relevant clinical variables will be collected from eligible patients with TBI and used to develop and validate the fREMS score.

Read the detailed description

Background Trauma is the leading cause of death worldwide, particularly in those younger than 35 years of age. Injuries and violence represent a major global public health issue. According to the World Health Organization (WHO), injuries and violence cause approximately 4.4 million deaths worldwide each year, accounting for nearly 8% of all deaths. Of these, about 3.16 million deaths are attributable to unintentional injuries and 1.25 million to violence-related injuries. Injuries and violence also contribute substantially to disability, with an estimated 10% of all years lived with disability attributed to these conditions.

Trauma severity scoring systems are important adjuncts to trauma care and are used to characterize the nature and extent of injury. They can support triage and assist in assessing and predicting patient outcomes, thereby helping to organize and improve trauma care systems. Trauma scoring systems can be divided into anatomical, physiological, and combined scores, each with advantages and disadvantages. The combination of the anatomic scoring system and the physiological scoring system is better than a single scoring system for death prediction in patients with severe trauma in the ICU, and it may be considered to be a new method for early identification of death risk in patients with severe trauma.

The Rapid Emergency Medicine Score (REMS) is a physiological scoring system developed from the Acute Physiology and Chronic Health Evaluation II (APACHE II), which is considered a more rapid and less invasive version and is used for rapid risk stratification and prediction of mortality. It includes several parameters: age, mean arterial pressure, respiratory rate, pulse rate, peripheral oxygen saturation, and Glasgow Coma Scale (GCS). The modified REMS (mREMS) was subsequently developed specifically for trauma by substituting systolic blood pressure for mean arterial pressure, reducing the weighting of age, and increasing the weighting of GCS; in a large validation cohort, mREMS showed an AUROC of 0.967 for predicting in-hospital mortality.

The Glasgow Coma Scale (GCS) provides an objective method for assessing the level of impaired consciousness in patients with acute medical conditions or trauma and is one of the most widely used neurological assessment scales. It evaluates three components of responsiveness: eye-opening, verbal, and motor responses, with each component reported separately to provide a detailed description of neurological status. The individual scores can also be combined into a total GCS score, providing a concise indication of overall severity. The GCS is widely used in trauma, emergency, and critical care settings and supports clinical assessment, triage, monitoring, and communication among healthcare professionals.

The Glasgow Coma Scale (GCS) has several limitations that can affect its reliability and clinical interpretation. The verbal component cannot be assessed reliably in patients who are intubated, pharmacologically sedated, or unable to speak, resulting in missing GCS values and limiting the use of the total score for prognostic models. The Glasgow Coma Scale (GCS) is limited in its ability to evaluate patients with concomitant head and spinal cord injury. Also, a comatose patient receives a GCS score of 3, which coincidentally matches the Glasgow Coma Scale (GCS) assigned to a deceased individual. Drug and alcohol intoxication can interfere with GCS assessment in trauma patients. DiGiorgio et al. found that intoxicated patients had greater changes in Glasgow Coma Scale (GCS) assigned scores than patients without detected substances, suggesting that intoxication may contribute to an initially depressed or variable Glasgow Coma Scale (GCS) assigned. The authors therefore recommended considering and addressing intoxicants when interpreting GCS scores to improve the accuracy of assessment and benchmarking. Painful stimuli used in the Best Eye and Best Motor Response assessments can complicate scoring, especially in polytrauma patients with spinal cord injuries.

The Full Outline of UnResponsiveness (FOUR) score is a coma scale consisting of four components: eye response, motor response, brainstem reflexes, and respiration, with each component assigned a maximum score of 4.

A study prospectively evaluated the Full Outline of UnResponsiveness (FOUR) score in 120 intensive care unit patients and compared it with the GCS among neuroscience nurses, neurology residents, and neurointensivists. The Full Outline of Unresponsiveness (FOUR) score further distinguished patients with the lowest Glasgow Coma Scale (GCS) scores and provided greater neurological detail by assessing brainstem reflexes, breathing patterns, different stages of herniation, and recognizing locked-in syndrome. The probability of in-hospital mortality was higher among patients with the lowest total FOUR score compared with those with the lowest total Glasgow Coma Scale (GCS) score.

In patients with traumatic brain injury, the Full Outline of Unresponsiveness (FOUR) score has been used as a predictor of outcome, and all components of the Full Outline of UnResponsiveness (FOUR) score can be assessed in intubated patients, because it does not include a verbal component. In a study of 51 Traumatic brain injury (TBI) patients, the area under the ROC curve for predicting in-hospital mortality was 0.93 for the Full Outline of UnResponsiveness (FOUR) score and 0.89 for the Glasgow Coma Scale (GCS).

Despite the established prognostic value of REMS and the FOUR score in critically ill and trauma patients, their combined use for mortality prediction in patients with traumatic brain injury (TBI) remains insufficiently explored. The incorporation of GCS within REMS may limit its applicability in severe TBI, particularly when the verbal component cannot be reliably assessed in intubated or sedated patients. The FOUR score may overcome this limitation by providing a more comprehensive neurological assessment without requiring a verbal response. Therefore, integrating the FOUR score with the physiological parameters of REMS may provide a simple and clinically applicable tool for early mortality risk stratification in TBI. Accordingly, this study aimed to develop and internally validate the FOUR-Rapid Emergency Medicine Score (fREMS) for predicting in-hospital mortality among patients with TBI.

02

Conditions studied

  • TBI
  • TBI Traumatic Brain Injury

Keywords

  • TBI
  • fREMS
  • Trauma score
03

In context

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 117 across 557 observational studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Al-Nahrain University is the lead sponsor of 26 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of adult patients (≥16 years) with acute traumatic brain injury (TBI).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with sufficient clinical data to calculate the fREMS score, including the FOUR Score and other required physiological variables.
  • Patients with a documented mortality outcome .

Exclusion criteria

Exclusion Criteria:

  • Patients transferred from another hospital after initial resuscitation.
  • Patients who died before the required initial clinical assessment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. In hospital mortality

    Mortality (death) during hospitalization

    Time frame: In-Hospital Phase (average of 15 days through discharge)

07

Study locations

1 site
  • College Of Medicine - Nahrain University
    Baghdad, Baghdad Governorate 10011, Iraq
    • Abdulillah R. Khamees, MBBCH · Contactabdulilah.r.khamis@gmail.com · 07838571013
    • · Contactabdulilah.r.khamis@gmail.com
    • Abdulillah R. Khamees, MBBCH · Principal investigator
    • Mustafa Mohammed Jassim, MBBCH · Sub investigator
    • Saja J Abotaleb, MBBCH · Sub investigator
    • Faiza Mohanad Shihab, MBBCH · Sub investigator
08

References and documents

Publications

  • Xiao Y, Jin H, Mei H, Liu X, Chen T, Liu Z, Jiang D, Zhou J, Yan J, Liang H. [The predictive value of combination of anatomic scoring system and physiological scoring system in prediction of death in patients with severe trauma: a multicenter analysis of 614 cases]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Apr;27(4):291-4. doi: 10.3760/cma.j.issn.2095-4352.2015.04.013. Chinese. PubMed 25891460 ↗
  • Beuran M, Negoi I, Paun S, Runcanu A, Gaspar B, Vartic M. [Trauma scores: a review of the literature]. Chirurgia (Bucur). 2012 May-Jun;107(3):291-7. Romanian. PubMed 22844826 ↗
  • Omar A, Winkelmann M, Liodakis E, Clausen JD, Graulich T, Omar M, Krettek C, Macke C. Applicability of Anatomic and Physiologic Scoring Systems for the Prediction of Outcome in Polytraumatized Patients with Blunt Aortic Injuries. Diagnostics (Basel). 2021 Nov 21;11(11):2156. doi: 10.3390/diagnostics11112156. PubMed 34829503 ↗
  • Rapsang AG, Shyam DC. Scoring systems of severity in patients with multiple trauma. Cir Esp. 2015 Apr;93(4):213-21. doi: 10.1016/j.ciresp.2013.12.021. Epub 2014 Jul 8. English, Spanish. PubMed 25015031 ↗
  • Alberdi F, Garcia I, Atutxa L, Zabarte M; Trauma and Neurointensive Care Work Group of the SEMICYUC. Epidemiology of severe trauma. Med Intensiva. 2014 Dec;38(9):580-8. doi: 10.1016/j.medin.2014.06.012. Epub 2014 Sep 18. English, Spanish. PubMed 25241267 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07816016
Lead sponsor
Al-Nahrain University
Responsible party
Abdulillah R. Khamees (Principal Investigator, Al-Nahrain University) — Principal investigator
First posted
Sep 11, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Abdulillah R. Khamees, MBBCH
Contact
abdulilah.r.khamis@gmail.com
07838571013

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion